Company / Operating Cash Flow per Share
ENvue Medical, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$66.40
FY2025
5-year range
-$66.40 / -$0.17
FY2021-FY2025
Trend
-242.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -243% YoY in FY2025, a notable deviation from the 9-year average annual change of -260%.
Based on SEC 10-K filings.
-66.40 in FY2025.
Declined from $-4.29 to $-66.40 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENvue Medical, Inc.'s operating cash flow per share has declined for 4 consecutive years.
- In FY2025, operating cash flow per share decreased 242.9% year-over-year.
- Peak operating cash flow per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$66.40 | -242.9% |
| FY2024 | -$19.36 | -351.7% |
| FY2023 | -$4.29 | -37.4% |
| FY2022 | -$3.12 | -1726.1% |
| FY2021 | -$0.17 | +81.5% |
| FY2020 | -$0.92 | +1.3% |
| FY2019 | -$0.93 | -68.4% |
| FY2018 | -$0.55 | +4.8% |
| FY2017 | -$0.58 | -2.7% |
| FY2016 | -$0.57 | +89.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026